Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cazzola

Showing results (1-10 of 802) with videos related to

Pageof 81
Sort By:
Blood|March 12, 2016
Mutant calreticulin: when a chaperone becomes intrusiveMario Cazzola
The New England Journal of Medicine|September 30, 2020
Myelodysplastic SyndromesMario Cazzola
Haematologica|December 24, 2002
Practice guidelines for the therapy of primary myelodysplastic syndromes: a word of caution about their translation into clinical practiceMario Cazzola
Blood|December 21, 2021
Ineffective erythropoiesis and its treatmentMario Cazzola
Respiration; International Review of Thoracic Diseases|April 30, 2018
Indacaterol/Glycopyrronium in Clinical Practice: The Italian ExperienceMario Cazzola
Haematologica|February 12, 2002
Novel genes, proteins, and inherited disorders of iron overload: iron metabolism is less boring than thoughtMario Cazzola
Nature Clinical Practice. Oncology|November 3, 2005
Can EPO reduce blood transfusion requirements during induction therapy for high-risk neuroblastoma?Mario Cazzola
Haematologica|August 1, 2009
Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndromeMario Cazzola
Therapeutic Advances in Respiratory Disease|March 19, 2009
From large clinical trials to management of COPD in the real worldMario Cazzola
Respiration; International Review of Thoracic Diseases|June 24, 2009
Genuair is a good inhaler but an indirect comparison with other dry powder inhalers is inadequateMario Cazzola
Pageof 81

Showing results (1-10 of 802) with videos related to

Sort By:
Pageof 81
Blood|March 12, 2016
Mutant calreticulin: when a chaperone becomes intrusiveMario Cazzola
The New England Journal of Medicine|September 30, 2020
Myelodysplastic SyndromesMario Cazzola
Haematologica|December 24, 2002
Practice guidelines for the therapy of primary myelodysplastic syndromes: a word of caution about their translation into clinical practiceMario Cazzola
Blood|December 21, 2021
Ineffective erythropoiesis and its treatmentMario Cazzola
Respiration; International Review of Thoracic Diseases|April 30, 2018
Indacaterol/Glycopyrronium in Clinical Practice: The Italian ExperienceMario Cazzola
Haematologica|February 12, 2002
Novel genes, proteins, and inherited disorders of iron overload: iron metabolism is less boring than thoughtMario Cazzola
Nature Clinical Practice. Oncology|November 3, 2005
Can EPO reduce blood transfusion requirements during induction therapy for high-risk neuroblastoma?Mario Cazzola
Haematologica|August 1, 2009
Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndromeMario Cazzola
Therapeutic Advances in Respiratory Disease|March 19, 2009
From large clinical trials to management of COPD in the real worldMario Cazzola
Respiration; International Review of Thoracic Diseases|June 24, 2009
Genuair is a good inhaler but an indirect comparison with other dry powder inhalers is inadequateMario Cazzola
Pageof 81